Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
This study has been completed.
Study NCT00865904   Information provided by Vertex Pharmaceuticals Incorporated

First Received on March 18, 2009.   Last Updated on April 13, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystic Fibrosis
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
VX-809
VX-809 Placebo
Sponsors listed in this trial
Vertex Pharmaceuticals Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services